Shaohua Ren

421 total citations
31 papers, 301 citations indexed

About

Shaohua Ren is a scholar working on Immunology, Molecular Biology and Hepatology. According to data from OpenAlex, Shaohua Ren has authored 31 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Molecular Biology and 7 papers in Hepatology. Recurrent topics in Shaohua Ren's work include Reproductive System and Pregnancy (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Cancer Mechanisms and Therapy (5 papers). Shaohua Ren is often cited by papers focused on Reproductive System and Pregnancy (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Cancer Mechanisms and Therapy (5 papers). Shaohua Ren collaborates with scholars based in China and United States. Shaohua Ren's co-authors include Hongming Ji, Yafei Qin, Bo Shao, Tianqiang Song, Hao Wang, Xinmin Ding, Hongda Wang, Peng Zou, Fuqiang Feng and Hong-da Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Shaohua Ren

29 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaohua Ren China 11 135 84 49 42 42 31 301
Feng Hong China 11 158 1.2× 70 0.8× 32 0.7× 20 0.5× 64 1.5× 24 301
Yaping Dong China 10 100 0.7× 60 0.7× 23 0.5× 49 1.2× 32 0.8× 20 259
Jianzhuang Ren China 12 180 1.3× 102 1.2× 34 0.7× 88 2.1× 46 1.1× 26 401
Yonglian Zeng China 13 196 1.5× 147 1.8× 36 0.7× 24 0.6× 37 0.9× 23 339
Zhibin Lin China 9 125 0.9× 59 0.7× 27 0.6× 27 0.6× 31 0.7× 16 237
Jietao Lin China 12 136 1.0× 67 0.8× 19 0.4× 54 1.3× 59 1.4× 39 380
Ming–Heng Wu Taiwan 8 201 1.5× 108 1.3× 55 1.1× 66 1.6× 62 1.5× 9 435
Xiaodi Yan China 12 290 2.1× 136 1.6× 57 1.2× 57 1.4× 51 1.2× 30 430

Countries citing papers authored by Shaohua Ren

Since Specialization
Citations

This map shows the geographic impact of Shaohua Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaohua Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaohua Ren more than expected).

Fields of papers citing papers by Shaohua Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaohua Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaohua Ren. The network helps show where Shaohua Ren may publish in the future.

Co-authorship network of co-authors of Shaohua Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Shaohua Ren. A scholar is included among the top collaborators of Shaohua Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaohua Ren. Shaohua Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Hongyu, Bo Shao, Wei Zhao, et al.. (2025). Analysis of nanomedicine applications for inflammatory bowel disease: structural and temporal dynamics, research hotspots, and emerging trends. Frontiers in Pharmacology. 15. 1523052–1523052. 2 indexed citations
3.
Li, Shilong, Conglin Wang, Shaohua Ren, et al.. (2025). CD73-expressing endometrial regenerative cell-derived exosomes mitigate acute cardiac allograft rejection through regulating adenosine metabolism in mice. Stem Cell Research & Therapy. 16(1). 277–277. 1 indexed citations
4.
Shao, Bo, Hong-da Wang, Shaohua Ren, et al.. (2025). Exosomes derived from a mesenchymal-like endometrial regenerative cells ameliorate renal ischemia reperfusion injury through delivery of CD73. Stem Cell Research & Therapy. 16(1). 148–148. 5 indexed citations
5.
Chen, Qiang, Bo Shao, Yini Xu, et al.. (2024). IGF2 contributes to the immunomodulatory effects of exosomes from endometrial regenerative cells on experimental colitis. International Immunopharmacology. 140. 112825–112825. 2 indexed citations
6.
Ren, Shaohua, et al.. (2024). Recombinant human IL-37 attenuates acute cardiac allograft rejection in mice. Cytokine. 179. 156598–156598. 1 indexed citations
7.
Ren, Shaohua, Dongming Liu, Guangtao Li, et al.. (2024). Lenvatinib, sintilimab combined interventional treatment vs bevacizumab, sintilimab combined interventional treatment for intermediate-advanced unresectable hepatocellular carcinoma. World Journal of Gastroenterology. 30(43). 4620–4635. 2 indexed citations
8.
Ren, Shaohua, et al.. (2024). Oxymatrine combined with rapamycin to attenuate acute cardiac allograft rejection. Heliyon. 10(8). e29448–e29448. 3 indexed citations
10.
Shao, Bo, Shaohua Ren, Hongda Wang, et al.. (2023). CD73 mediates the therapeutic effects of endometrial regenerative cells in concanavalin A-induced hepatitis by regulating CD4+ T cells. Stem Cell Research & Therapy. 14(1). 277–277. 3 indexed citations
11.
Ren, Shaohua, Guangtao Li, Yayue Liu, et al.. (2023). A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 673–686. 16 indexed citations
12.
Xu, Yini, Qiang Chen, Yafei Qin, et al.. (2023). Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance‐mediated oxaliplatin chemoresistance in colorectal cancer. Molecular Carcinogenesis. 63(2). 224–237. 13 indexed citations
13.
Li, Ning, Shaohua Ren, Yafei Qin, et al.. (2022). Four‐Pyroptosis Gene‐Based Nomogram as a Novel Strategy for Predicting the Effect of Immunotherapy in Hepatocellular Carcinoma. BioMed Research International. 2022(1). 2680110–2680110. 2 indexed citations
14.
Ren, Shaohua, Guangtao Li, Fang Fěng, et al.. (2022). Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study. SHILAP Revista de lepidopterología. Volume 9. 799–810. 9 indexed citations
15.
Shao, Bo, Yafei Qin, Shaohua Ren, et al.. (2022). Structural and Temporal Dynamics of Mesenchymal Stem Cells in Liver Diseases From 2001 to 2021: A Bibliometric Analysis. Frontiers in Immunology. 13. 859972–859972. 26 indexed citations
16.
Qin, Yafei, Shaohua Ren, Bo Shao, et al.. (2022). The intellectual base and research fronts of IL-37: A bibliometric review of the literature from WoSCC. Frontiers in Immunology. 13. 931783–931783. 25 indexed citations
17.
Ren, Shaohua, et al.. (2020). <p>Nimodipine Improves Cognitive Impairment After Subarachnoid Hemorrhage in Rats Through IncRNA NEAT1/miR-27a/MAPT Axis</p>. Drug Design Development and Therapy. Volume 14. 2295–2306. 13 indexed citations
18.
Ren, Shaohua, et al.. (2019). The lncRNA DAPK-IT1 regulates cholesterol metabolism and inflammatory response in macrophages and promotes atherogenesis. Biochemical and Biophysical Research Communications. 516(4). 1234–1241. 28 indexed citations
19.
Ren, Shaohua, et al.. (2017). Linarin suppresses glioma through inhibition of NF-κB/p65 and up-regulating p53 expression in vitro and in vivo. Biomedicine & Pharmacotherapy. 95. 363–374. 41 indexed citations
20.
Ren, Shaohua, et al.. (2017). Hyperhomocysteinemia as a Risk Factor for Saccular Intracranial Aneurysm: A Cohort Study in a Chinese Han Population. Journal of Stroke and Cerebrovascular Diseases. 26(12). 2720–2726. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026